CV

Cedric Ververken

Chief Executive Officer

Confo Therapeutics

Ghent, Flanders


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Confo Therapeutics
Industry
biotechnology
Employees
74.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
112194363.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Mobile Friendly WordPress.org Gravity Forms Typekit Nginx Google Maps (Non Paid Users) Google Maps Google Tag Manager Google Font API

Keywords

drug discovery antibody technology g protein coupled receptors drug development gpcr therapeutics metabolic diseases endocrine diseases biotherapeutics small molecules antibody-based therapies clinical-stage agonists antagonists inverse agonists allosteric modulators pain management neuropathic pain at2r gpr75 sstr5 sstr4 mc1r pthr1 confobody confochimer confosensor confostructure phase 1 phase 2 lead optimization target validation immunogenic antigens high-throughput screening cell-based assays biotech pharmaceutical partnerships investor consortium vhh domains biologic drug candidates innovative treatments preclinical studies therapeutic breakthroughs collaborative research unmet medical needs pharmaceutical collaborations antibody discovery multi-gen platform drug targeting precision medicine receptor targeting patient outcomes

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans